Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer, June 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 118 articles:
HTML format


 

Single Articles

  1. DONG P, Xiong Y, Yu J, Chen L, et al
    Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
    Oncogene. 2018 May 31. pii: 10.1038/s41388-018-0347.
    Abstract    

    Abstract available

  2. DU R, Li L, Ma S, Tan X, et al
    Lymph nodes metastasis in cervical cancer: Incidences, risk factors, consequences and imaging evaluations.
    Asia Pac J Clin Oncol. 2018 May 31. doi: 10.1111/ajco.12997.
    Abstract    

    Abstract available

  3. CONG Q, Song Y, Wang Q, Zhang H, et al
    A Large Retrospective Study of 12714 Cases of LEEP Conization Focusing on Cervical Cancer That Colposcopy-Directed Biopsy Failed to Detect.
    Biomed Res Int. 2018;2018:5138232.
    Abstract    

    Abstract available

  4. WANG L, Zhao Y, Wang Y, Wu X, et al
    The Role of Galectins in Cervical Cancer Biology and Progression.
    Biomed Res Int. 2018;2018:2175927.
    Abstract    

    Abstract available

  5. MOSHI FV, Vandervort EB, Kibusi SM
    Cervical Cancer Awareness among Women in Tanzania: An Analysis of Data from the 2011-12 Tanzania HIV and Malaria Indicators Survey.
    Int J Chronic Dis. 2018;2018:2458232.
    Abstract    

    Abstract available

  6. WANG DG, Li TM, Liu X
    RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-beta1.
    Biochem Biophys Res Commun. 2018 May 28. pii: S0006-291X(18)31260.
    Abstract    

    Abstract available

  7. CHUNG CP, Lee SJ, Wakabayashi MT
    Uterine and Cervical Cancer with Irreducible Pelvic Organ Prolapse.
    Am J Obstet Gynecol. 2018 May 28. pii: S0002-9378(18)30431.
    Abstract    



  8. MA L, Liu JM, Zhang J, Li H, et al
    A pilot study of oral S-1 for treating heavily pretreated patients with advanced or recurrent cervical cancer among Chinese population.
    Medicine (Baltimore). 2018;97:e10922.
    Abstract    

    Abstract available

  9. HE Y, Zhao Q, Geng YN, Yang SL, et al
    Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational st
    Medicine (Baltimore). 2018;97:e10913.
    Abstract    

    Abstract available

  10. FENG C, Dong J, Chang W, Cui M, et al
    The Progress of Methylation Regulation in Gene Expression of Cervical Cancer.
    Int J Genomics. 2018;2018:8260652.
    Abstract    

    Abstract available

  11. VAZQUEZ-SANCHEZ AY, Hinojosa LM, Parraguirre-Martinez S, Gonzalez A, et al
    Expression of KATP channels in human cervical cancer: Potential tools for diagnosis and therapy.
    Oncol Lett. 2018;15:6302-6308.
    Abstract    

    Abstract available

  12. TZAFETAS M, Mitra A, Kalliala I, Lever S, et al
    Fertility-sparing Surgery for Presumed Early-stage Invasive Cervical Cancer: A Survey of Practice in the United Kingdom.
    Anticancer Res. 2018;38:3641-3646.
    Abstract    

    Abstract available

  13. AHN SY, Li C, Zhang X, Hyun YM, et al
    Mitofusin-2 Expression Is Implicated in Cervical Cancer Pathogenesis.
    Anticancer Res. 2018;38:3419-3426.
    Abstract    

    Abstract available

  14. FLANAGAN MB
    Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States: Is It Time?
    Arch Pathol Lab Med. 2018;142:688-692.
    Abstract    

    Abstract available

  15. BOGNAR Z, Fekete K, Bognar R, Szabo A, et al
    Amiodarone's major metabolite, desethylamiodarone induces apoptosis in human cervical cancer cells.
    Can J Physiol Pharmacol. 2018 May 30. doi: 10.1139/cjpp-2018-0113.
    Abstract    

    Abstract available

  16. FERNANDES ETBS, Nascimento ERD, Ferreira SL, Coelho EAC, et al
    Cervical cancer prevention among quilombola women in the light of Leininger's theory.
    Rev Gaucha Enferm. 2018;39:e2016-4.
    Abstract    

    Abstract available

  17. GORDON C, Carmichael JC, Tewari KS
    Oncofertility in the setting of advanced cervical cancer - A case report.
    Gynecol Oncol Rep. 2018;24:27-29.
    Abstract    

    Abstract available

  18. TRUONG PK, Lao TD, LE TAH
    Hypermethylation of DcR1 Gene-based Biomarker in Non-invasive Cancer Screening of Vietnamese Cervical Cancer Patients.
    Iran J Public Health. 2018;47:350-356.
    Abstract    

    Abstract available

  19. BHUIYAN A, Sultana F, Islam JY, Chowdhury MAK, et al
    Knowledge and Acceptance of Human Papillomavirus Vaccine for Cervical Cancer Prevention Among Urban Professional Women in Bangladesh: A Mixed Method Study.
    Biores Open Access. 2018;7:63-72.
    Abstract    

    Abstract available

  20. YANG X, Da M, Zhang W, Qi Q, et al
    Role of Lactobacillus in cervical cancer.
    Cancer Manag Res. 2018;10:1219-1229.
    Abstract    

    Abstract available

  21. SO D, Shin HW, Kim J, Lee M, et al
    Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense.
    Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0339.
    Abstract    

    Abstract available

  22. KIM H, Houser CJ, Kalash R, Maceil CA, et al
    Workflow and efficiency in MRI-based high-dose-rate brachytherapy for cervical cancer in a high-volume brachytherapy center.
    Brachytherapy. 2018 May 26. pii: S1538-4721(18)30083.
    Abstract    

    Abstract available

  23. BARCHUK A, Bespalov A, Huhtala H, Chimed T, et al
    Breast and cervical cancer incidence and mortality trends in Russia 1980-2013.
    Cancer Epidemiol. 2018;55:73-80.
    Abstract    

    Abstract available

  24. XIA X, Zhou X
    Knockdown of SIRT1 inhibits proliferation and promotes apoptosis of paclitaxel-resistant human cervical cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2018;64:36-41.
    Abstract    

    Abstract available

  25. FRANKART AJ, Meier T, Minges TL, Kharofa J, et al
    Comparison of spinal and general anesthesia approaches for MRI-guided brachytherapy for cervical cancer.
    Brachytherapy. 2018 May 25. pii: S1538-4721(18)30060.
    Abstract    

    Abstract available

  26. XU LJ, Duan Y, Wang P, Yin HQ, et al
    MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
    Biochem Biophys Res Commun. 2018 May 25. pii: S0006-291X(18)31242.
    Abstract    

    Abstract available

  27. SHARMA D, Rohilla L, Bagga R, Srinivasan R, et al
    Feasibility of implementing cervical cancer screening program using smartphone imaging as a training aid for nurses in rural India.
    Public Health Nurs. 2018 May 28. doi: 10.1111/phn.12517.
    Abstract    

    Abstract available

  28. SOOD S, Patel FD, Srinivasan R, Dhaliwal LK, et al
    Chemoradiation therapy induces in vivo changes in gene promoter methylation & gene transcript expression in patients with invasive cervical cancer.
    Indian J Med Res. 2018;147:151-157.
    Abstract    

    Abstract available

  29. HE X, Li JP, Liu XH, Zhang JP, et al
    Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors.
    J Cancer. 2018;9:1877-1884.
    Abstract    

    Abstract available

  30. QI J, Liu G, Wang F
    High levels of centrosomal protein 55 expression is associated with poor clinical prognosis in patients with cervical cancer.
    Oncol Lett. 2018;15:9347-9352.
    Abstract    

    Abstract available

  31. LIU L, Lai X, Yuan C, Lv X, et al
    Aberrant expression of miR-153 is associated with the poor prognosis of cervical cancer.
    Oncol Lett. 2018;15:9183-9187.
    Abstract    

    Abstract available

  32. ZHAO L, Zhang Z, Lou H, Liang J, et al
    Exploration of the molecular mechanisms of cervical cancer based on mRNA expression profiles and predicted microRNA interactions.
    Oncol Lett. 2018;15:8965-8972.
    Abstract    

    Abstract available

  33. QIN G, Li P, Xue Z
    Effect of allyl isothiocyanate on the viability and apoptosis of the human cervical cancer HeLa cell line in vitro.
    Oncol Lett. 2018;15:8756-8760.
    Abstract    

    Abstract available

  34. LI Z, Fan P, Deng M, Zeng C, et al
    The roles of RUNX3 in cervical cancer cells in vitro.
    Oncol Lett. 2018;15:8729-8734.
    Abstract    

    Abstract available

  35. LI X, Bau T, Bao H
    FPOA induces apoptosis in HeLa human cervical cancer cells through a caspase-mediated pathway.
    Oncol Lett. 2018;15:8357-8362.
    Abstract    

    Abstract available

  36. HE GF, Mu TL, Pan YS, Chen ZH, et al
    [Inhibitory effect of DAPT on Notch signaling pathway in curcumin mediated photodynamic therapy for cervical cancer xenografts in nude mice].
    Zhonghua Yi Xue Za Zhi. 2018;98:1511-1516.
    Abstract    

    Abstract available

  37. AKINLOTAN MA, Weston C, Bolin JN
    Individual- and county-level predictors of cervical cancer screening: a multi-level analysis.
    Public Health. 2018;160:116-124.
    Abstract    

    Abstract available

  38. PHALIWONG P, Pariyawateekul P, Khuakoonratt N, Sirichai W, et al
    Cervical Cancer Detection between Conventional and Liquid Based Cervical Cytology: a 6-Year Experience in Northern Bangkok Thailand
    Asian Pac J Cancer Prev. 2018;19:1331-1336.
    Abstract    

    Abstract available

  39. NOGUEIRA RODRIGUES A, Melo AC, Alves FVG, Vilaca MN, et al
    Lack of Impact of Race Alone on Cervical Cancer Survival in Brazil
    Asian Pac J Cancer Prev. 2018;19:1209-1214.
    Abstract    

    Abstract available

  40. JIN X, Jiao X, Jiao J, Zhang T, et al
    Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Gene. 2018 May 22. pii: S0378-1119(18)30585-7. doi: 10.1016/j.gene.2018.
    Abstract    

    Abstract available

  41. ZHAO XL, Yu CZ
    Vosaroxin induces mitochondrial dysfunction and apoptosis in cervical cancer HeLa cells: Involvement of AMPK/Sirt3/HIF-1 pathway.
    Chem Biol Interact. 2018;290:57-63.
    Abstract    

    Abstract available

  42. RASPOLLINI MR, Lax SF, McCluggage WG
    The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.
    Virchows Arch. 2018 May 24. pii: 10.1007/s00428-018-2372.
    Abstract    

    Abstract available

  43. XIA L, Wang M, Li H, Tang X, et al
    The effect of aberrant expression and genetic polymorphisms of Rad21 on cervical cancer biology.
    Cancer Med. 2018 May 24. doi: 10.1002/cam4.1592.
    Abstract    

    Abstract available

  44. KINNEY WK, Perkins RB, Sawaya GF
    Equal Management of Equal Risks: What Should be Used as the Standard for Cervical Cancer Prevention?
    J Low Genit Tract Dis. 2018 May 22. doi: 10.1097/LGT.0000000000000402.
    Abstract    



  45. LI PP, Li B, Wang YT, Liu SH, et al
    [Prognostic analysis of stage b2 anda2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Zhonghua Fu Chan Ke Za Zhi. 2018;53:248-256.
    Abstract    

    Abstract available

  46. MARTINEZ-LAVIN M
    Comment on: "Safety of Human Papillomavirus Vaccines: An Updated Review".
    Drug Saf. 2018;41:539-540.
    Abstract    



  47. CHANDLER RE, Edwards IR, Lindquist M
    Comment on "Safety of Human Papillomavirus Vaccines: An Updated Review".
    Drug Saf. 2018;41:537-538.
    Abstract    



  48. MIRANDA AE, Silveira MF, Travassos AG, Tenorio T, et al
    High-risk Papillomavirus infection among Women living with Human Immunodeficiency Virus: Brazilian multicentric study.
    J Med Virol. 2017 Aug 3. doi: 10.1002/jmv.24906.
    Abstract    

    Abstract available

  49. LUQUE JS, Tarasenko YN, Chen C
    Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013-2014.
    J Prim Prev. 2018 Jun 6. pii: 10.1007/s10935-018-0513.
    Abstract    

    Abstract available

  50. SHAO J, Wang C, Li L, Liang H, et al
    Luteoloside Inhibits Proliferation and Promotes Intrinsic and Extrinsic Pathway-Mediated Apoptosis Involving MAPK and mTOR Signaling Pathways in Human Cervical Cancer Cells.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  51. ZEFERINO LC, Bastos JB, Vale DBAPD, Zanine RM, et al
    Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil.
    Rev Bras Ginecol Obstet. 2018 Jun 6. doi: 10.1055/s-0038-1657754.
    Abstract    

    Abstract available

  52. ZIDI S, Sahli M, Mezlini A, Yacoubli-Loueslati B, et al
    Association of Combined Tobacco Smoking, Hormonal Contraceptive use and Status Matrimonial with Cervical Cancer Evolution in Tunisian Women.
    Pathol Oncol Res. 2018 Jun 5. pii: 10.1007/s12253-018-0442.
    Abstract    

    Abstract available

  53. TANG M, Liu Q, Zhou L, Chen L, et al
    The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer.
    Invest New Drugs. 2018 Jun 6. pii: 10.1007/s10637-018-0616.
    Abstract    

    Abstract available

  54. PRASAD N, Sabarwal A, Yadav UCS, Singh RP, et al
    Lupeol induces S-phase arrest and mitochondria-mediated apoptosis in cervical cancer cells.
    J Biosci. 2018;43:249-261.
    Abstract    

    Abstract available

  55. DILLNER J, Sparen P, Andrae B, Strander B, et al
    [Cervical cancer has increased in Sweden in women who had a normal cell sample].
    Lakartidningen. 2018;115.
    Abstract    

    Abstract available

  56. ADAM JA, Arkies H, Hinnen K, Stalpers LJ, et al
    18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.
    Q J Nucl Med Mol Imaging. 2018 Jun 4. pii: S1824-4785.18.03083.
    Abstract    

    Abstract available

  57. KUNOS CA, Ivy SP
    Triapine Radiochemotherapy in Advanced Stage Cervical Cancer.
    Front Oncol. 2018;8:149.
    Abstract    

    Abstract available

  58. WANG Q, Qin Q, Song R, Zhao C, et al
    NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression.
    Cell Death Dis. 2018;9:668.
    Abstract    

    Abstract available

  59. SOUZA RP, de Souza Bonfim-Mendonca P, Damke GMZF, De Assis Carvalho ARB, et al
    Artepillin C induces selective oxidative stress and inhibits migration and invasion in a comprehensive panel of human cervical cancer cell lines.
    Anticancer Agents Med Chem. 2018 Jun 3. pii: ACAMC-EPUB-90883.
    Abstract    

    Abstract available

  60. JAMIESON A, Brand A
    Response to: Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?
    Aust N Z J Obstet Gynaecol. 2018;58:E5-E6.
    Abstract    



  61. NICKLIN J, Morgan EL
    Author's Right of Reply: Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?
    Aust N Z J Obstet Gynaecol. 2018;58:E6.
    Abstract    



  62. ZOU SH, Du X, Lin H, Wang PC, et al
    Paclitaxel inhibits the progression of cervical cancer by inhibiting autophagy via lncRNARP11-381N20.2.
    Eur Rev Med Pharmacol Sci. 2018;22:3010-3017.
    Abstract    

    Abstract available

  63. WANG CH, Li YH, Tian HL, Bao XX, et al
    Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/beta-catenin signaling pathway.
    Eur Rev Med Pharmacol Sci. 2018;22:3002-3009.
    Abstract    

    Abstract available

  64. ZHOU J, Liu X, Wang CH, Wang D, et al
    Decreased expression of miR-1254 is associated with cancer aggressiveness and predicts poor outcome in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2018;22:2997-3001.
    Abstract    

    Abstract available

  65. GUO F, Cofie LE, Berenson AB
    Cervical Cancer Incidence in Young U.S. Females After Human Papillomavirus Vaccine Introduction.
    Am J Prev Med. 2018 May 30. pii: S0749-3797(18)31641.
    Abstract    

    Abstract available

  66. PALSDOTTIR K, Epstein E
    A Pilot Study on Diagnostic Performance of Contrast-Enhanced Ultrasonography for Detection of Early Cervical Cancer.
    Ultrasound Med Biol. 2018 May 30. pii: S0301-5629(18)30180.
    Abstract    

    Abstract available

  67. SAFIGHOLI H, Han DY, Soliman A, Song WY, et al
    Direction Modulated Brachytherapy (DMBT) Tandem Applicator for Cervical Cancer Treatment: Choosing the Optimal Shielding Material.
    Med Phys. 2018 Jun 2. doi: 10.1002/mp.13030.
    Abstract    

    Abstract available

  68. ZHANG W, Zhang A, Sun W, Yue Y, et al
    Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia and human papilloma virus infection: A systematic review and meta-analysis of randomized clinical trials.
    Medicine (Baltimore). 2018;97:e10864.
    Abstract    

    Abstract available

  69. PARVEEN N, Sikander R, Majida, Shaheen, et al
    Spectrum of Gynecological Malignancies at Jamshoro.
    J Coll Physicians Surg Pak. 2018;28:52-55.
    Abstract    

    Abstract available

  70. YANG H, Hu H, Gou Y, Hu Y, et al
    Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
    Int J Clin Oncol. 2018;23:321-328.
    Abstract    

    Abstract available

  71. YAHATA H, Sonoda K, Yasunaga M, Ohgami T, et al
    Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1).
    Asia Pac J Clin Oncol. 2018;14:e50-e53.
    Abstract    

    Abstract available

  72. WANG CH, Shyu RY, Wu CC, Chen ML, et al
    Tazarotene-Induced Gene 1 Interacts with DNAJC8 and Regulates Glycolysis in Cervical Cancer Cells.
    Mol Cells. 2018 Jun 14. pii: molcells.2018.2347.
    Abstract    

    Abstract available

  73. MUNGUIA-MORENO JA, Diaz-Chavez J, Garcia-Villa E, Albino-Sanchez ME, et al
    Early synergistic interactions between the HPV16E7 oncoprotein and 17beta-oestradiol for repressing the expression of Granzyme B in a cervical cancer model.
    Int J Oncol. 2018 Jun 6. doi: 10.3892/ijo.2018.4432.
    Abstract    

    Abstract available

  74. KANG MA, Kim W, Jo HR, Shin YJ, et al
    Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS032, on cervical cancer.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4424.
    Abstract    

    Abstract available

  75. HWANG SH, Shin HY, Lee DO, Sung NY, et al
    A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening.
    Sci Rep. 2018;8:9015.
    Abstract    

    Abstract available

  76. WANG L, Dai G, Yang J, Wu W, et al
    Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by g-Secretase Inhibitor RO4929097.
    Med Sci Monit. 2018;24:4046-4053.
    Abstract    

    Abstract available

  77. DABI Y, Willecocq C, Ballester M, Carcopino X, et al
    Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer.
    J Transl Med. 2018;16:163.
    Abstract    

    Abstract available

  78. LU R, Yang Z, Xu G, Yu S, et al
    miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
    Biomed Pharmacother. 2018;105:633-644.
    Abstract    

    Abstract available

  79. ZOU W, Hu C, Feng Y, Wang J, et al
    Treatment Protocols for Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer.
    J Clin Oncol. 2018 Jun 13:JCO2018788893. doi: 10.1200/JCO.2018.78.8893.
    Abstract    



  80. GUPTA VG, Goel V
    Differences Between Chemotherapy-Resistant Disease and Inoperable Disease in Cervical Cancer Treated With Neoadjuvant Chemotherapy.
    J Clin Oncol. 2018 Jun 13:JCO2018786632. doi: 10.1200/JCO.2018.78.6632.
    Abstract    



  81. HOU W, Mao M, Shen Z, Chen Y, et al
    HOXD-AS1 exerts oncogenic functions and promotes chemoresistance in cisplatin-resistant cervical cancer cells.
    Hum Gene Ther. 2018 Jun 13. doi: 10.1089/hum.2017.
    Abstract    

    Abstract available

  82. CELEWICZ A, Celewicz M, Wezowska M, Chudecka-Glaz A, et al
    Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
    Pol J Pathol. 2018;69:42-47.
    Abstract    

    Abstract available

  83. FIRMINO-MACHADO J, Varela S, Mendes R, Moreira A, et al
    Stepwise strategy to improve cervical cancer screening adherence (SCAN-Cervical Cancer) - Automated text messages, phone calls and reminders: Population based randomized controlled trial.
    Prev Med. 2018 Jun 9. pii: S0091-7435(18)30194.
    Abstract    



  84. SWANSON M, Ueda S, Chen LM, Huchko MJ, et al
    Evidence-based improvisation: Facing the challenges of cervical cancer care in Uganda.
    Gynecol Oncol Rep. 2018;24:30-35.
    Abstract    

    Abstract available

  85. NGOI NYL, Heong V, Lee XW, Huang YQ, et al
    Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer.
    Gynecol Oncol Rep. 2018;24:1-5.
    Abstract    

    Abstract available

  86. AMINI A, Robin TP, Rusthoven CG, Schefter TE, et al
    Disparities Predict for Higher Rates of Cut-through Hysterectomies in Locally Advanced Cervical Cancer.
    Am J Clin Oncol. 2018 Jun 7. doi: 10.1097/COC.0000000000000473.
    Abstract    

    Abstract available

  87. KULLMANN T, Sipocz I, Agyemang-Prempeh K, Barna O, et al
    [Paclitaxel containing chemotherapeutic regimens in first line and reintroduced palliative treatment of metastatic cervical cancer].
    Orv Hetil. 2018;159:974-977.
    Abstract    

    Abstract available

  88. SKELTON WP 4TH, Castagno J, Cardenas-Goicoechea J, Daily K, et al
    Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review.
    Clin Med Insights Oncol. 2018;12:1179554918779587.
    Abstract    

    Abstract available

  89. QIU H, Li J, Liu Q, Tang M, et al
    Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
    Cell Cycle. 2018 Jun 9. doi: 10.1080/15384101.2018.1471315.
    Abstract    

    Abstract available

  90. MEMON MM, Amin E
    Cervical cancer caused by human papillomavirus: Highly preventable yet highly under-diagnosed.
    J Pak Med Assoc. 2018;68:831.
    Abstract    



  91. MCGREGOR S, Saulo D, Brotherton J, Liu B, et al
    Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30771.
    Abstract    

    Abstract available

  92. NEGA AD, Woldetsadik MA, Gelagay AA
    Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.
    BMC Womens Health. 2018;18:87.
    Abstract    

    Abstract available

  93. KI EY, Lee YK, Lee A, Park JS, et al
    Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
    Yonsei Med J. 2018;59:662-668.
    Abstract    

    Abstract available

  94. TAXIMAIMAITI R, Abudujilile D, Maihemuti M, Abuliken X, et al
    Expression of AMHR2 and C-KIT in cervical lesions in Uyghur Women of Xinjiang, China.
    Medicine (Baltimore). 2018;97:e10793.
    Abstract    

    Abstract available

  95. GADDUCCI A, Landoni F, Cosio S, Zizioli V, et al
    Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Anticancer Res. 2018;38:3627-3634.
    Abstract    

    Abstract available

  96. CHUNG T, DO SI, Na K, Kim G, et al
    Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix.
    Anticancer Res. 2018;38:3551-3558.
    Abstract    

    Abstract available

  97. FENG M, Zou J, Zhang Y, Sun L, et al
    [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Zhonghua Bing Li Xue Za Zhi. 2018;47:328-333.
    Abstract    

    Abstract available

  98. ZHAO S, Zhao FH
    [Research progress of HPV therapeutic vaccine].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:556-560.
    Abstract    

    Abstract available

  99. WANG YY, Lin W, Wu B, Yuan SX, et al
    [Distribution and associated factors of high-risk HPV genotypes infection among HPV-positive women who participated cervical screening test in Shenzhen, 2014-2016, China].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:480-485.
    Abstract    

    Abstract available

  100. XU XQ, Zhang L, Hu SY, Rezhake R, et al
    [Role of HPV viral loads in random biopsy under normal colposcopy].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:475-479.
    Abstract    

    Abstract available

  101. ZHAO XL, Remila R, Hu SY, Zhang L, et al
    [Comparison of screening performance between primary high-risk HPV screening and high-risk HPV screening plus liquid-based cytology cotesting in diagnosis of cervical precancerous or cancerous lesions].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:469-474.
    Abstract    

    Abstract available

  102. PERNOT S, Pavie J, Pere H, Menard M, et al
    [Papillomavirus, could we speak about cancer and prevention?]
    Bull Cancer. 2018;105:137-139.
    Abstract    



  103. HE ZH, Kou ZQ, Xu AQ
    [Human papillomavirus infection and vaccination].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:106-112.
    Abstract    

    Abstract available

  104. HAN YF, Zhuang YN, Li Y, Fang Y, et al
    [Analysis of mothers' acceptance of HPV vaccination of adolescent girls in Xiamen].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:38-42.
    Abstract    

    Abstract available

  105. WANG Y, Yu X, Song H, Feng D, et al
    The STAT-ROS cycle extends IFNinduced cancer cell apoptosis.
    Int J Oncol. 2018;52:305-313.
    Abstract    

    Abstract available

  106. CARDOSO ICR, Aredes MA, Chaves GV
    Applicability of the direct parameters of bioelectrical impedance in assessing nutritional status and surgical complications of women with gynecological cancer.
    Eur J Clin Nutr. 2017 Aug 9. doi: 10.1038/ejcn.2017.
    Abstract    

    Abstract available

  107. HEO I, Kwak HJ, Nah EH, Cho S, et al
    Evaluation of the LC-1000 Flow Cytometry Screening System for Cervical Cancer Screening in Routine Health Checkups.
    Acta Cytol. 2018 May 29:1-9. doi: 10.1159/000489079.
    Abstract    

    Abstract available

  108. MISRA JS, Srivastava AN, Gupta HP
    Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
    Acta Cytol. 2018 Jun 13:1-6. doi: 10.1159/000489078.
    Abstract    

    Abstract available

  109. FUGLSANG K, Haldorsen IS, Lundqvist EA, Lindahl G, et al
    Cervical cancer staging, pretreatment planning and surgical treatment in the Nordic countries - survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology.
    Acta Obstet Gynecol Scand. 2018 May 24. doi: 10.1111/aogs.13388.
    Abstract    

    Abstract available

  110. YAGUR Y, Weitzner O, Gemer O, Lavie O, et al
    Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study.
    Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30903.
    Abstract    

    Abstract available

  111. SALVO G, Frumovitz M, Pareja R, Lee J, et al
    Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (>/=2cm) cervical cancer: Bridging the gap to fetal viability.
    Gynecol Oncol. 2018 May 24. pii: S0090-8258(18)30908.
    Abstract    

    Abstract available

  112. BERGENGREN L, Kaliff M, L Larsson G, Karlsson MG, et al
    Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
    Int J Gynaecol Obstet. 2018 Jun 1. doi: 10.1002/ijgo.12538.
    Abstract    

    Abstract available

  113. NASSALI MN, Tadele M, Nkuba RM, Modimowame J, et al
    Predictors of Locally Advanced Disease at Presentation and Clinical Outcomes Among Cervical Cancer Patients Admitted at a Tertiary Hospital in Botswana.
    Int J Gynecol Cancer. 2018 May 23. doi: 10.1097/IGC.0000000000001284.
    Abstract    

    Abstract available

  114. LI R, Shinde A, Chen YJ, Amini A, et al
    Survival benefit of adjuvant brachytherapy after hysterectomy with positive surgical margins in cervical cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jun 8. pii: S0360-3016(18)30929.
    Abstract    

    Abstract available

  115. ZHAN Y, Zhang H, Dai B, Zhang Y, et al
    A novel biphenyl urea compound, TPD7, stimulates apoptosis through modulating Fas signaling and Bcl-2 family proteins in cervical cancer.
    Oncol Rep. 2018 Jun 4. doi: 10.3892/or.2018.6472.
    Abstract    

    Abstract available

  116. LEE J, Wu MH, Chen YJ
    Delineation guideline for the para-aortic lymph node region in cervical cancer.
    Radiother Oncol. 2018 May 26. pii: S0167-8140(18)30251.
    Abstract    



  117. JENSEN NBK, Potter R, Kirchheiner K, Fokdal L, et al
    Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study.
    Radiother Oncol. 2018 Jun 4. pii: S0167-8140(18)30275.
    Abstract    

    Abstract available

  118. GININDZA TG, Sartorius B
    Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates.
    BMC Cancer. 2018;18:639.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;